Bruce Booth sold $56.5M of KYMR stock

Bruce Booth, Dir of Kymera Therapeutics, Inc. (KYMR), sold 513,245 shares of KYMR stock worth $56.5M, per an SEC Form 4 filed Jun 30, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 26, 2026, 4 days before it was made public.

KYMR has moved +18.0% since the trade date, from $108.12 to $127.57 (Nov 13, 2026 close).